Basics Arvinas, Inc. IPO Date: September 24, 2018 Sector: Healthcare Industry: Biotech Market Cap: $591.44M Activated in VL: True Average Daily Range Avg Daily Range: $1.12 | 2.96% Avg Daily Range (30 D): $0.24 | 3.14% Avg Daily Range (90 D): $0.48 | 3.39% Institutional Daily Volume Avg Daily Volume: .48M Avg Daily Volume (30 D): 2.27M Avg Daily Volume (90 D): 1.64M Trade Size Avg Trade Size (Sh.): 66 Avg Trade Size (Sh.) (30 D): 96 Avg Trade Size (Sh.) (90 D): 88 Institutional Trades Total Inst.Trades: 2,925 Avg Inst. Trade: $2.2M Avg Inst. Trade (30 D): $1.98M Avg Inst. Trade (90 D): $1.89M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.68M Avg Closing Trade (30 D): $2.32M Avg Closing Trade (90 D): $2.45M Avg Closing Volume: 72.25K         News Apr 4, 2025 @ 11:00 AM Arvinas Presents First-in-Human Data for Investiga... Source: N/A Mar 27, 2025 @ 11:00 AM Arvinas Announces Oral Presentation at 2025 Intern... Source: Arvinas, Inc. Jan 21, 2025 @ 9:29 AM 2 Growth Stocks That Could Rocket Higher in the Fi... Source: Cory Renauer Dec 10, 2024 @ 6:23 PM Arvinas-Pfizer Partner Cancer Drug Trial Shows 63%... Source: Vandana Singh Nov 27, 2024 @ 12:00 PM Arvinas to Present at Piper Sandler 36th Annual He... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-4.79 $-.68 $-.49 Diluted EPS $-4.79 $-.68 $-.49 Revenue $ 161.1M $ 102.4M $ 76.5M Gross Profit $ $ $ Net Income / Loss $ -308.6M $ -49.2M $ -35.2M Operating Income / Loss $ -357.4M $ -60.3M $ -48.5M Cost of Revenue $ $ $ Net Cash Flow $ -34M $ -75.1M $ 66.8M PE Ratio